XIANGBISHAN Trademark

Trademark Overview


On Thursday, December 7, 2000, a trademark application was filed for XIANGBISHAN with the United States Patent and Trademark Office. The USPTO has given the XIANGBISHAN trademark a serial number of 76177243. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 19, 2010. This trademark is owned by GUILIN SANJIN PHARMACEUTICAL GROUP CO.,LTD.. The XIANGBISHAN trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely pharmaceutical preparations for the treatment of cancer, diabetes, Parkinson's disease, lupus, multiple sclerosis, Alzheimer's disease, senile dementia, hemophilia, vertigo, ophthalmopathy, otorhinolaryngologic disease, pneumonia, emphysema, respiratory system disease, hepatitis, fatty liver, cirrhosis, Chron's disease, gastritis, gastric ulcer, alimentary system disease, nephritis, urinary system infection, prostatitis, arthritis, cardiovascular disease, cerebrovascular disease and traumatic bleeding; traditional Chinese medicines for use in the treatment of insomnia, headaches, diabetes, cold, pharyngitis, upper respiratory tract infection, gastritis, gastric ulcer, enteritis, hepatitis, alimentary system disease, nephritis, prostatitis, urinary system infection, genital system infection, gynopathy, obesity, otorhinolaryngologic disease, hypertension, hyperlipemia, cardiovascular disease, cerebrovascular disease and arthritis; medicine liquor, nam...
xiangbishan

General Information


Serial Number76177243
Word MarkXIANGBISHAN
Filing DateThursday, December 7, 2000
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 19, 2010
Registration Number2832403
Registration DateTuesday, April 13, 2004
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 1, 2003

Trademark Statements


Goods and ServicesMedicines for human purposes, namely pharmaceutical preparations for the treatment of cancer, diabetes, Parkinson's disease, lupus, multiple sclerosis, Alzheimer's disease, senile dementia, hemophilia, vertigo, ophthalmopathy, otorhinolaryngologic disease, pneumonia, emphysema, respiratory system disease, hepatitis, fatty liver, cirrhosis, Chron's disease, gastritis, gastric ulcer, alimentary system disease, nephritis, urinary system infection, prostatitis, arthritis, cardiovascular disease, cerebrovascular disease and traumatic bleeding; traditional Chinese medicines for use in the treatment of insomnia, headaches, diabetes, cold, pharyngitis, upper respiratory tract infection, gastritis, gastric ulcer, enteritis, hepatitis, alimentary system disease, nephritis, prostatitis, urinary system infection, genital system infection, gynopathy, obesity, otorhinolaryngologic disease, hypertension, hyperlipemia, cardiovascular disease, cerebrovascular disease and arthritis; medicine liquor, namely, liquor for medical purposes; herbal supplements, namely, Chinese herbal medicinal materials; vitamin preparations, namely, vitamin supplements, vitamin and mineral supplements; nutritional substances for medical purpose, namely, food for medically restricted diets, food for diabetics, meal replacement drinks and powders, nutritional supplements; biological products, namely, biological preparations for diagnosis and treatment of diseases, namely, menopause syndrome, depression and tumor; sanitary products, namely, tampons, menstruation pads, Chinese-medicine bags for health care purposes and gummed tape for medicinal purposes
Lining/Stippling StatementThe lining shown in the mark is merely to indicate shading.
Translation of Words in Markthe transliteration of the Chinese characters in the mark is "XIANG BI SHAN;" the English translation is "elephant", "nose", and "mountain".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 19, 2010
Primary Code005
First Use Anywhere DateSunday, December 30, 1990
First Use In Commerce DateMonday, December 30, 2002

Trademark Owner History


Party NameGUILIN SANJIN PHARMACEUTICAL GROUP CO.,LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGuilin
CN

Party NameGUILIN SANJIN PHARMACEUTICAL GROUP CO.,LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGuilin
CN

Party NameGUILIN SANJIN PHARMACEUTICAL GROUP CO.,LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGuilin
CN

Trademark Events


Event DateEvent Description
Friday, November 19, 2010CANCELLED SEC. 8 (6-YR)
Tuesday, April 13, 2004REGISTERED-PRINCIPAL REGISTER
Saturday, February 7, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, February 2, 2004ASSIGNED TO EXAMINER
Thursday, January 29, 2004CASE FILE IN TICRS
Wednesday, January 14, 2004STATEMENT OF USE PROCESSING COMPLETE
Friday, December 12, 2003USE AMENDMENT FILED
Friday, December 12, 2003PAPER RECEIVED
Tuesday, June 24, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 1, 2003PUBLISHED FOR OPPOSITION
Wednesday, March 12, 2003NOTICE OF PUBLICATION
Wednesday, January 22, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 16, 2003EXPARTE APPEAL RECEIVED AT TTAB
Thursday, September 19, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 2, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 2, 2002PAPER RECEIVED
Friday, September 20, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 20, 2002PAPER RECEIVED
Thursday, March 21, 2002FINAL REFUSAL MAILED
Wednesday, January 9, 2002ASSIGNED TO EXAMINER
Tuesday, October 2, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 12, 2001NON-FINAL ACTION MAILED
Tuesday, April 3, 2001ASSIGNED TO EXAMINER